Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Change in Receivables (2016 - 2025)

STRATA Skin Sciences (SSKN) has disclosed Change in Receivables for 14 consecutive years, with $630000.0 as the latest value for Q4 2025.

  • Quarterly Change in Receivables fell 5.69% to $630000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 million through Dec 2025, down 258.95% year-over-year, with the annual reading at -$1.0 million for FY2025, 258.95% down from the prior year.
  • Change in Receivables hit $630000.0 in Q4 2025 for STRATA Skin Sciences, up from -$568000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $899000.0 in Q4 2022 to a low of -$929000.0 in Q2 2025.
  • Historically, Change in Receivables has averaged $56100.0 across 5 years, with a median of $141000.0 in 2021.
  • Biggest five-year swings in Change in Receivables: skyrocketed 1072.09% in 2023 and later tumbled 414.92% in 2025.
  • Year by year, Change in Receivables stood at $309000.0 in 2021, then surged by 190.94% to $899000.0 in 2022, then tumbled by 129.7% to -$267000.0 in 2023, then soared by 350.19% to $668000.0 in 2024, then decreased by 5.69% to $630000.0 in 2025.
  • Business Quant data shows Change in Receivables for SSKN at $630000.0 in Q4 2025, -$568000.0 in Q3 2025, and -$929000.0 in Q2 2025.